Steve Deitsch

Steve Deitsch is a seasoned med-tech executive with over 16 years of experience as a CFO across both public and private companies. They have held significant roles, including CFO at Biomet Group during its merger with Zimmer, and have contributed to several significant organizational successes, such as the sale of BioScrip, Inc. to Option Care Health. Currently, they serve as CFO at OrganOx and as a board member for both Aclarion and Auddia. Steve’s foundational education includes a Bachelor of Science in Accounting from Ball State University.